Table 1 Clinical characteristics of the patients with nasopharyngeal carcinoma stratified by low and high expression of Talin-1
Characteristic | No. of patients | Expression of talin-1 | P-value* | |
|---|---|---|---|---|
| Â | Â | Low, n (%) | High, n (%) | Â |
Age | Â | Â | Â | Â |
≤45 years | 114 | 87 (76.3) | 27 (23.7) | 0.09 |
>45Â years | 119 | 79 (66.4) | 40 (33.6) | Â |
Sex | Â | Â | Â | Â |
Male | 169 | 124 (73.4) | 45 (26.6) | 0.24 |
Female | 64 | 42 (65.6) | 22 (34.4) | Â |
WHO type | Â | Â | Â | Â |
I + II | 8 | 4 (50.0) | 4 (50.0) | 0.23 |
III | 225 | 162 (72.0) | 63 (28.0) | Â |
VCA-IgA | Â | Â | Â | Â |
<1:80 | 35 | 27 (77.1) | 8(22.9) | 0.40 |
≥1:80 | 198 | 139 (70.2) | 59(29.8) |  |
EA-IgA | Â | Â | Â | Â |
<1:10 | 57 | 42 (73.7) | 15 (26.3) | 0.64 |
≥1:10 | 176 | 124 (70.5) | 52 (29.5) |  |
T Stage | Â | Â | Â | Â |
T1-T2 | 113 | 85 (75.2) | 28 (24.8) | 0.19 |
T3-T4 | 120 | 81 (67.5) | 39 (32.5) | Â |
N Stage | Â | Â | Â | Â |
N0-N1 | 143 | 103 (72.0) | 40 (28.0) | 0.74 |
N2-N3 | 90 | 63 (70.0) | 27 (30.0) | Â |
TNM stage | Â | Â | Â | Â |
I-II | 72 | 56 (77.8) | 16 (22.2) | 0.14 |
III-IV | 161 | 110 (68.3) | 51(31.7) | Â |
Locoregional failure | ||||
Yes | 39 | 23 (59.0) | 16 (41.0) | 0.06 |
No | 194 | 143 (73.7) | 51 (26.3) | Â |
Distant metastasis | ||||
Yes | 51 | 27 (52.9) | 24 (47.1) | 0.001 |
No | 182 | 139 (76.4) | 43 (23.6) | Â |
Death | Â | Â | Â | Â |
Yes | 57 | 31 (54.4) | 26 (45.6) | 0.001 |
No | 176 | 135 (76.7) | 41 (23.3) | Â |